Substances · Arylcyclohexylamines
Ketamine
- Preferred name
- Ketamine
- IUPAC name
- 2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one
- Parent CAS number (reference)
- 6740-88-1
- Molecular formula
- C13H16ClNO
- Molecular weight
- 237.72 g/mol
- InChIKey
- YQEZLKZALYSWHR-UHFFFAOYSA-N
- PubChem
- CID 3821
- Source
- PubChem
- Verified synonyms & catalog abbreviations
-
Ketamina CI-581 2-Chloro-2'-oxo-PCM
Matching Listings in This Store's Catalog
Verified Neurochemical & Toxicological Intelligence
Ketamine
Receptor Telemetry & Mechanism of Action
Uncompetitive NMDA receptor channel blocker (Ki = 500 nM) with rapid distribution and short elimination (T1/2 ~2.5 h).
Biotransformation & Active Metabolites
Rapid hepatic CYP3A4/2B6 N-demethylation to norketamine and hydroxynorketamine.
Temporal Pharmacokinetics
Short-Acting Reference NMDA Receptor Antagonist — Shortest-acting dissociative benchmark; lower oral bioavailability than 2-FDCK; chronic frequent exposure carries documented ketamine cystitis / urological bladder toxicity.
- Onset 15–30 min
- Peak Window 30–60 min
- Total Window 1–2.5 h
- Residual / Half-Life 1–3 h mild ataxia
Shortest-acting dissociative benchmark; lower oral bioavailability than 2-FDCK; chronic frequent exposure carries documented ketamine cystitis / urological bladder toxicity.
Quantitative Response Spectrum (Published Literature)
Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.
15–30 mg
Subtle threshold receptor activity (Short-Acting Reference NMDA Receptor Antagonist).
Minimal baseline autonomic shift.
30–75 mg
Mild, clear-headed expression of primary class profile.
Light somatic modulation.
75–150 mg
Full characteristic neurochemical and perceptual profile documented in literature.
Moderate somatic relaxation, ataxia, or autonomic tone depending on class.
150–250 mg
Pronounced intensity, cognitive/motor impairment, or deep immersion.
Marked somatic load and heightened adverse-event sensitivity.
300+ mg
Amnesia, blackout, acute dysphoria, confusion, or anesthetic dissociation.
High toxicity zone: severe motor loss, cardiovascular strain, or respiratory hazard.
Interaction Matrix & Critical Contraindications
Critical Hazard — Never Combine
Severe ataxia, unconsciousness, respiratory depression, and fatal vomiting aspiration.
Elevated Hazard — Avoid
Compounds hypertension, tachycardia, manic disorientation, and psychotic episodes.
Caution / Receptor Attenuation
Dramatically intensifies dissociation, confusion, and sensory immersion.
Structural Isomer & Sibling Comparison
Shortest-acting dissociative benchmark; lower oral bioavailability than 2-FDCK; chronic frequent exposure carries documented ketamine cystitis / urological bladder toxicity.
Physicochemical Stability & Storage
Form: White to off-white crystalline powder or fine crystals. · Soluble in water, ethanol, and saline.
Chemically stable when kept dry, sealed, and protected from light at room temperature.
Cross-Tolerance & Dependence Profile
Slowly decaying NMDA cross-tolerance shared across all arylcyclohexylamines (halves in ~3–7 days, full baseline 2+ weeks). Chronic frequent exposure carries documented urological/bladder epithelial toxicity.
Chemical Architecture & Structural Profile
Ketamine (2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one) is a reference compound belonging to the Arylcyclohexylamines class, characterized by the molecular formula C13H16ClNO and a molar mass of 237.72 g/mol. The parent molecule is indexed under CAS registry number 6740-88-1 and in the NCBI PubChem database as CID 3821 (Standard InChIKey: YQEZLKZALYSWHR-UHFFFAOYSA-N).
Citations
- PubChem — PubChem (2026-11-12)
Reference Toxicology & Safety Profile
In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), Ketamine is indexed within the Arylcyclohexylamines structural group. Arylcyclohexylamine derivative; toxicological literature highlights severe hazard interactions when combined with central nervous system depressants (alcohol, GHB/GBL, opioids, benzodiazepines). Dependence liability (PsychonautWiki): moderate to high abuse potential and produces psychological dependence with chronic use. Documented cross-tolerance class: dissociative. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.
Citations
- PubChem — PubChem (2026-11-12)
Analytical Use & Laboratory Notice
This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.
Citations
- Gesetze im Internet — Neue-psychoaktive-Stoffe-Gesetz (NpSG) & BtMG — Bundesministerium der Justiz (2026-11-12)